Dystonia as a manifestation of neuropsychiatric lupus erythematosus (NPSLE) is uncommon. We report a 25-year-old woman who experienced progressive confusion, reduced speech, and difficulty opening her mouth approximately 2 weeks after development of a facial rash. Brain imaging showed bilateral, symmetric signal abnormalities within the basal ganglia and subcortical white matter. Despite treatment with high-dose steroids, she continued to have difficulty speaking with evidence of jaw dystonia on examination. Jaw dystonia rapidly improved with the initiation of levodopa. Repeat evaluation 3 months later exhibited the absence of jaw dystonia and near resolution of the imaging abnormalities. Our patient demonstrated a unique presentation with jaw dystonia refractory to traditional treatment for NPSLE. Such a presentation likely represents a severe variant of NPSLE requiring both immunosuppressive and symptomatic therapies.
The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum. 1999;42(4):599–608.
2.
AinialaHHietaharjuALoukkolaJ. Validity of the new American College of Rheumatology criteria for neuropsychiatric lupus syndromes: a population-based evaluation. Arthritis Rheum. 2001;45(5):419–423.
3.
AinialaHLoukkolaJPeltolaJKorpelaMHietaharjuA. The prevalence of neuropsychiatric syndromes in systemic lupus erythematosus. Neurology. 2001;57(3):496–500.
4.
BreyRLHollidaySLSakladAR. Neuropsychiatric syndromes in lupus: prevalence using standardized definitions. Neurology. 2002;58(8):1214–1220.
5.
HanlyJGMcCurdyGFougereLDouglasJAThompsonK. Neuropsychiatric events in systemic lupus erythematosus: attribution and clinical significance. J Rheumatol. 2004;31(11):2156–2162.
6.
Hermosillo-RomoDBreyRL. Diagnosis and management of patients with neuropsychiatric systemic lupus erythematosus (NPSLE). Best Pract Res Clin Rheumatol. 2002;16(2):229–244.
7.
SannaGBertolacciniMLCuadradoMJ. Neuropsychiatric manifestations in systemic lupus erythematosus: prevalence and association with antiphospholipid antibodies. J Rheumatol. 2003;30(5):985–992.
8.
SergentJSLockshinMDKlempnerMSLipskyBA. Central nervous system disease in systemic lupus erythematosus. Therapy and prognosis. Am J Med. 1975;58(5):644–654.
9.
SibbittWLJrBrandtJRJohnsonCR. The incidence and prevalence of neuropsychiatric syndromes in pediatric onset systemic lupus erythematosus. J Rheumatol. 2002;29(7):1536–1542.
10.
HanlyJGUrowitzMBSanchez-GuerreroJ; Systemic Lupus International Collaborating Clinics. Neuropsychiatric events at the time of diagnosis of systemic lupus erythematosus: an international inception cohort study. Arthritis Rheumat. 2007;56(1):265–273.
11.
YuHHLeeJHWangLCYangYHChiangBL. Neuropsychiatric manifestations in pediatric systemic lupus erythematosus: a 20-year study. Lupus. 2006;15(10):651–657.
12.
BernatskySClarkeAGladmanDD. Mortality related to cerebrovascular disease in systemic lupus erythematosus. Lupus. 2006;15(12):835–839.
13.
BertsiasGKBoumpasDT. Pathogenesis, diagnosis and management of neuropsychiatric SLE manifestations. Nat Rev Rheumatol. 2010;6(6):358–367.
WuKChristodoulouLSiddiquiAD’CruzDAndrewsT. Bilateral reversible basal ganglia changes associated with dystonia and hemifacial spasms in central nervous system lupus. Quant Imaging Med Surg. 2015;5(6):928–929.
16.
Baizabal-CarvalloJFBonnetCJankovicJ. Movement disorders in systemic lupus erythematosus and the antiphospholipid syndrome. J Neural Trans (Vienna). 2013;120(11):1579–1589.
17.
GoebVDubreuilFCabrePJean-BaptisteGArfiS. Lupus revealing itself after a stiff-person syndrome. Lupus. 2004;13(3):215.
18.
MunhozRPFameliHTeiveHA. Stiff person syndrome as the initial manifestation of systemic lupus erythematosus. Mov Disord. 2010;25(4):516–517.
19.
RobertMSunithaRThulaseedharanNK. Neuropsychiatric manifestations systemic lupus erythematosus: a study from South India. Neurol India. 2006;54(1):75–77.
20.
VenegoniEBiasioliRLampertiERinaldiESalmaggiANoviC. Tremor as an early manifestation of systemic lupus erythematosus. Clin Exp Rheumatol. 1994;12(2):199–201.
21.
BonfaEGolombekSJKaufmanLD. Association between lupus psychosis and anti-ribosomal P protein antibodies. N Engl J Med. 1987;317(5):265–271.
22.
HirohataSArinumaYTakayamaMYoshioT. Association of cerebrospinal fluid anti-ribosomal P protein antibodies with diffuse psychiatric/neuropsychological syndromes in systemic lupus erythematosus. Arthritis Res Ther. 2007;9(3):R44.
23.
Garcia-MorenoJMChaconJ. Juvenile parkinsonism as a manifestation of systemic lupus erythematosus: case report and review of the literature. Mov Disord. 2002;17(6):1329–1335.
KwongKLChuRWongSN. Parkinsonism as unusual neurological complication in childhood systemic lupus erythematosus. Lupus. 2000;9(6):474–477.
26.
SibbittWLJrSibbittRRBrooksWM. Neuroimaging in neuropsychiatric systemic lupus erythematosus. Arthritis Rheum. 1999;42(10):2026–2038.
27.
IshikawaOOhnishiKMiyachiYIshizakaH. Cerebral lesions in systemic lupus erythematosus detected by magnetic resonance imaging. Relationship to anticardiolipin antibody. J Rheumatol. 1994;21(1):87–90.
28.
ProvenzaleJMBarboriakDPAllenNBOrtelTL. Patients with antiphospholipid antibodies: CT and MR findings of the brain. AJR Am J Roentgenol. 1996;167(6):1573–1578.
29.
SabetASibbittWLJrStidleyCADanskaJBrooksWM. Neurometabolite markers of cerebral injury in the antiphospholipid antibody syndrome of systemic lupus erythematosus. Stroke. 1998;29(11):2254–2260.
30.
LimSMOldfieldMAbbottRJ. Systemic lupus erythematosus presenting with steroid-responsive parkinsonism and post-hemiplegic dystonia. Eur J Neurol. 1998;5(3):309–312.
31.
Morales-BuenrostroLETellez-ZentenoJFEstanolB. Symptomatic hemiparkinsonism with abnormal spect in a patient with systemic lupus erythematosus (SLE) [in Spanish]. Neurologia. 2002;17(7):391–393.
32.
MedaoudSLouniciAZaibekA. Parkinsonian syndrome during the systemic lupus erythematosus: a case report [in French]. Rev Med Interne. 2003;24(12):839–841.
33.
OsawaHYamabeHKaizukaM. Systemic lupus erythematosus associated with transverse myelitis and parkinsonian symptoms. Lupus. 1997;6(7):613–615.
